Satoshi Takenaka, MD, PhD (he/him/his)

Director, Musculoskeletal Oncology Service
Osaka International Cancer Institute, Japan

Affiliation:
Director, Department of Orthopaedic Surgery, Osaka International Cancer Institute, Osaka, Japan
Degrees:
M.D. Osaka University School of Medicine, Osaka, Japan 1996
Ph.D. Osaka University School of Medicine, Osaka, Japan, 2010
Fellowship:
Department of orthopaedic surgery, Memorial Sloan Kettering Cancer Center, NY, USA, 2014
Past positions:
Assistant professor, Department of orthopaedic surgery, Osaka University, 2015
Awards:
SICOT Poster Presentation Award in 5th SICOT/SIROT Annual international conference. 2007
Excellent Presentation Award in 42th Musculoskeletal Tumor Meeting of Japanese Orthopaedic Association, 2009

Poster(s):

• (P 05) DEVELOPMENT OF SARCOMA ORGANOID MODELS WITH AIR-LIQUID INTERFACE ORGANOID CULTURES

• (P 96) TRACP-5B AS A BIOMARKER FOR LONG-TERM DENOSUMAB TREATMENT OF UNRESECTABLE GIANT CELL TUMOR OF BONE

• (P 272) OUTCOMES OF FOUR CASES OF TOTAL HIP ARTHROPLASTY (THA) WITH POROUS TANTALUM IMPLANT AFTER PARTIAL ACETABULAR RESECTION USING 3D PREOPERATIVE PLANNING FOR PELVIC BONE TUMORS

• (P 283) USE OF MIXED REALITY IN PELVIC BONE TUMOR RESECTION: FIVE CASE STUDY

• (P 387) SUCCESSFUL PAZOPANIB TREATMENT OF UNDIFFERENTIATED PLEOMORPHIC SARCOMA WITH COAMPLIFICATION OF PDGFRA, VEGFR2, AND KIT: A CASE REPORT